Diabetes has, without doubt, a genetic background. However, despite extensive research worldwide we have until now been unable to define the genetic lesions and the mode of inheritance of the different forms of the disease. In Type 1 (insulin-dependent) diabetes mellitus the high discordance for the disease in genetically identical twins indicates that the nuclear genetic component per se is not sufficient for full penetrance. Furthermore, the rapidly rising incidence of Type i diabetes [1] cannot be explained on a mendelian genetic basis, as the enrichment of the gene pool with a putative "diabetes gene", for example, by increased survival of young diabetic patients, would require several hundred years for dominant and several thousand years for recessive inheritance [2] . The increasing incidence of the disease is therefore most likely due to changes in environmental exposures. Furthermore, the incidence of Type i diabetes is quite different among various populations. Definite reasons for these extraordinary geographic differences remain unknown. Type 2 (non-insulin dependent) diabetes exhibits several features of a degenerative disorder and can thus possibly be attributed to a variety of degenerative processes associated with defects in oxidative phosphorylation.
In the following I will discuss the possibility that environmental factors could preferentially affect the second human genome, the mitochondrial DNA, thus leading to metabolic, immunologic, genetic and phylogenetic alterations.
The mitochondrial DNA
Eukaryotic cells usually contain one nuclear genome and up to several thousand identical copies of the mitochondrial DNA (mtDNA). The sequence of the human mt genome, 16,569 base pairs (bp) in length, was published in 1981 [3] . Unlike the nuclear DNA, which is linear, the double-stranded mtDNA is circular and has a highly compacted structure consisting almost entirely of coding regions. It is almost exclusively maternally inherited, uses its own genetic code and codes for 13 subunits of the respiratory chain complexes, 22 transfer RNAs (tRNA) and 2 ribosomal RNAs (rRNA). Mitochondria have their own transcription and translation apparatus. Besides their nuclear genetic diversity, populations differ in mtDNA types ("alleles, clusters"). During the last decade restriction analysis and sequencing revealed an extreme polymorphism of point and length mutations within the mt genome [4] . Obviously, non-random branching patterns occurred during the 300,000 years of evolution resulting in different mtDNA lineages [5, 6] , of which certain types seem relatively specific for one population.
The mtDNA is vulnerable
Although the mtDNA encodes highly conserved proteins it exhibits a very high mutation rate for the following reasons: The mt genome evolves 5-10 times faster than single copy nuclear DNA genes [7] . Its half-life is between 6-10 days in rat heart, liver and kidney compared to the nuclear DNA, which has a half-life of about 100 days in rat liver [7] . The mutability may also reflect the relatively high insertion error-rate of the mitochondrial DNA polymerase-7 of about 1/7000 bases, resulting in 2-3 mismatched nucleotides per round of replication of the 16.6 kilobases (kb) mt genome [8] . Furthermore, the mtDNA is more exposed to chemical attack than the nuclear DNA because it is not protected by histones. Mitochondria reduce about 90 % of the cell's oxygen; in man this equals about 2 x 102o molecules 02 per g of tissue per day [9] . Highly reactive oxygen species such as superoxide radicals, hydrogen peroxide and hydroxyl radicals are formed during aerobic metabolism along the mitochondrial respiratory chain. Even under normal conditions this oxidative stress leads to extensive damage especially of the mtDNA [10] . Since the mammalian mtDNA is highly organized and consists almost exclusively of coding regions, it is vulnerable. Thus, muta-tions could have functional significance. The lack of sufficient repair mechanisms of the mt genome confirms this view.
were also reported in brain sections from Alzheimer's patients [13] (Fig. 1) .
Alterations of mtDNA are associated with disease
During the last four years an increasing number of publications have shown that certain deletions, insertions or point mutations of the mtDNA are associated with distinct diseases (Fig. 1) . Large deletions or insertions are found in muscle mtDNA from patients with chronic progressive external ophthalmoplegia (CPEO) or the Kearns-Sayre syndrome (KSS) [11] , in the brain of patients with Parkinson's disease, in dilatative and hypertrophic cardiomyopathy, in haemopoetic cells from patients with Pearson's marrow-pancreas syndrome and as a general result of ageing in tissues of apparently healthy elderly people [12] . Several point mutations were described in large pedigrees of the maternally inherited Leber's hereditary opticus neuropathy (LHON), in myoclonus epilepsy with ragged red fibres (MERRF), in myoencephalopathy with lactic acidosis and stroke-like episodes (MELAS), and in other clinically undefined disorders [12] . Most recently distinct point mutations of the mtDNA
The action of diabetogenic agents
The action of various diabetogenic agents such as interleukin 113 (IL-113), interferon % tumour necrosis factor cq alloxan and streptozotocin (STZ) has been a subject of many excellent reviews during the last years. It is not the objective of this paper to repeat all the results contributed in this field. Briefly, there are at least two lines of operating mechanisms: i) the formation of free radicals such as nitric oxide (NO') and the oxygen hydroxyl radical ('OH); ii) alkylation of DNA and proteins (Fig. 2) . Formation of NO" occurs via L-arginine-dependent NO-synthase [14] . The mechanism, induced by IL-t[3, also operates in Beta cells, as recently demonstrated by electron paramagnetic resonance spectroscopy [15] . Prolonged exposure to IL-113 of islets leads to a decrease of insulin secretion and an impairment of mitochondrial oxidation [16] . The mechanism is the liberation of iron from the iron-sulphur clusters within the catalytically active centres of the complexes I and II of the respiratory chain and the Krebs-cycle enzyme aconitase and the formation of iron-nitrosyl corn- [12] ; the 10.4 kilobase (kb) deletion is unique as it is found only in the diabetic family described in [47] . CIPO, chronic intestinal pseudoobstruction with myopathy and ophthalmoplegia; NARP, neurogenic muscle weakness, ataxia and retinitis pigmentosa [15, 17] . NO'-generating compounds also inhibit DNA replication and stimulate ADP-ribosyltransferase [14] . NO', which is usually converted to N02-and NO3-can undergo another pathway [18] . The simultaneous generation of nitric oxide and superoxide produces hydroxyl radicals via peroxynitrite. This could explain the partially protective effect of radical scavengers against ILl[3 with respect to damage of Beta cells. STZ and alloxan generate H202 in isolated islets and lead to DNA fragmentation [19, 20] . Since superoxide and H202 do not per se undergo any chemical reactions with DNA the mechanism could either be the formation of "OH via reaction with metal ions or an acute rise in intracellular free Ca 2 +, which might fragment DNA by activating CaZ+-dependent endonucleases [21] . The hydroxyl radical "OH is extremely reactive attacking all components of the DNA. It can abstract hydrogen atoms from deoxyribose leading to direct release of purine and pyrimidine bases (abasic sites) or after incubation in alkaline solutions (alkali labile sites); it can add on to guanine and adenine, thus producing radical adducts with different fates [21] . The action of alloxan, but not STZ, can be prevented by addition of scavenger enzymes such as superoxide dismutase, catalase and glutathione reductase [22] . Inhibitors of the poly(ADP-ribose) synthetase, such as nicotinamide, benzamide etc., however, can prevent the development of diabetes induced by various diabetogenic agents in animal models [23] as well in humans [24] . These observations have led Okamoto [25] to hypothesise that all diabetogenic agents cause DNA strand breaks in islets resulting in the activation of the poly(ADP-ribose) synthetase mechanism, followed by NAD depletion and ultimately by death of Beta cells. Because STZ causes permanent defects in Beta cells independent of the NAD concentration, this hypothesis was recently questioned [26, 27] .
Evidence the mtDNA of Beta cells is preferentially attacked by diabetogenic agents in vitro and in vivo
Beta cells are known to contain very small amounts of scavenger enzymes, especially of mitochondrial Mnsuperoxide dismutase [22, 28] . The naked, i.e. non-histone-protected mtDNA resembles a mutation rate, which is 10-20 fold higher than in the nuclear genome. For example, among the various oxidation products caused by radical attack, 8-hydroxy-2-deoxyguanosine is formed in mtDNA at 16 times the level of nuclear DNA after incubation with the prooxidant alloxan [10] . This compound might induce a G. A mispair during replication leading to a G. C to T-A transformation mutation. The highly reactive hydroxyl radical "OH is also able to alter mitochondrial membrane lipids, a process which can be prevented by a-tocopherol, but not by scavenger enzymes [29] . STZ suppresses the mRNA of mtDNA encoded cytochrome b, but has no effect on the transcript of the nuclear encoded glyceraldehyde-3-P-dehydrogenase in adult rat islets [30] . In islets isolated from STZ-treated neonatal rats it selectively depresses the mtDNA as compared to nuclear DNA, and consequently lowers mitochondrial gene expression [31] .
Besides its ability to generate H202 and consequently hydroxyl radicals, STZ acts as an alkylating nitrosourea, which alkylates DNA at two main positions, the N 7-and the O6-position of guanine [26] . In the rat insulinoma cell line (RINr 38) STZ leads to the formation of alkali labile sites within the mtDNA [32] . The formation of methylated N7-guanine, which comprises about 70 % of the alkylated adducts after exposure to STZ is about four-fold higher in the mtDNA compared to the nuclear DNA. This is consistent with former findings which have demonstrated, that the mtDNA is a preferential target of alkylating agents [33] . In the RINr 38 cell line repair of the N 7-methylated sites seems to occur by an excision repair mechanism [32] . The efficiency of mitochondria in removing O6-alkylated sites varies between different cell types. It is high in parenchymal tissues such as the liver and lowest in "APUD" cells such as brain cells [34] . Sequencing of an approximately 200 bp segment surrounding the replication origin of the mtDNA of STZ-treated islets did not, however, lead to sequencial differences when compared to the published mtDNA [31] . From this study it seems likely that STZ induces an all-or-nothing injury of the mtDNA. However, since islets exposed to STZ in vitro can survive for several weeks with basal oxygen consumption but reduced insulin release, STZ may also lead to partial mtDNA damage under certain conditions [27, 35] .
Are mutated mitochondrial gene products expressed and can they act as autoantigens?
In KSS the so-called "common deletion", a 4,977 bp deletion flanked by a 13 bp repeat (Fig. 1) , produces a frame shift in the mt genome with three new triplets and a mito-chondrial stop codon [36, 37] . This artificial fusion gene is transcribed, but the translation product could not be found [36] . Most recently, however, it was shown [38] that the introduction of disease-related mtDNA deletions into HeLa cells results in transcription and translation of the artificial hybrid genes, in dysfunction of the respectively affected respiratory chain complexes and ultimately in cell death. In mice and rats it was demonstrated that mitochondrially encoded peptides can serve as MHC-restricted antigens [39] . Mta, a maternally inherited murine minor histocompatibility antigen, is homologous to the mtDNA encoded NDl-subunit of complex I of the respiratory chain (NADH-ubiquinone oxidoreductase) and consists of four alleles differing in the amino acid composition at position 6 of the NDl-subunit [39] . Oligopeptides with different amino acids at this position can serve as antigens for the development of highly specific T-cell clones, when inserted into the plasma membrane of target cells. Since islets isolated from in vivo STZ-treated mice can induce a specific T-cell response in culture [40] , STZinduced alterations on the surface of surviving Beta cells are likely. Although nothing is known about transport mechanisms of peptides from the mitochondrion to the endoplasmic reticulum and to the plasma membrane, the mouse and rat Mta-system prove that mitochondrially encoded self-peptides are normally displayed on the surface of cells [41] . Alterations of mtDNA encoded peptides could therefore contribute to the diversity of antigens. Keeping in mind the high mutability of the mt genome and the insufficient repair and scavenger mechanisms -especially in neuroendocrine cells -it seems reasonable that the mtDNA of Beta cells is one, if not the preferential target of diabetogenic noxae. A mutational event, once it occurred in a single mtDNA molecule, could provide an advantage for the mutated genome, for example by an enhanced replication of a shorter, i.e. deleted genome. If so, the number of mutated mtDNA molecules will increase. This may change the display of the mitochondrially encoded self-determinants on the surface of the Beta cells, resulting in a break of T-cell tolerance and in autoreactivity (Fig. 2) .
Clinical evidence that the mtDNA may be involved in the pathogenesis of diabetes
Patients with CPEO or KSS carrying large deletions of the mtDNA have an incidence rate for diabetes which seems several times higher than in the general population. In a group of 21 patients presented by Quade et al. [42] , three had Type i diabetes, two Type 2 diabetes and three impaired glucose tolerance. Association of mitochondrial encephalomyopathies with diabetes has already been mentioned by others [43, 44] . Of the 27 patients with both diseases, mitochondrial myopathy and diabetes, reported in the literature so far, at least 50 % are insulin-dependent. The earlier the onset of the mitochondrial myopathy the more frequent is its association with Type 1 diabetes [44] . Testing for islet cell antibodies was not performed, however, in any of the reported cases. Although no detailed studies have been published, single cases reported in the K.-D. Gerbitz: The role of the mitochondrial DNA in the pathogenesis of diabetes literature make it seem probable that also MELAS [45] and other mitochondrial cytopathies [46] are associated with diabetes. Since the mutation of the mt genome seems thus far to be the only genetic defect in these forms of disorders, the association of both diseases, mitochondrial myopathy and diabetes, makes it likely that alterations of the mtDNA of Beta cells to some degree contribute to the development of diabetes. Most recently [47] first direct evidence was given that alterations of the mtDNA can in fact cause diabetes. A systemic 10.4 kb mtDNA deletion was found in a family with maternally inherited insulindependent diabetes (Fig. 1) . Maternal transmission was also reported in a large family with Type 2 diabetes carrying a rare polymorphic mtDNA restriction site [48] (Fig. 1) .
Intergenomic interactions
Replication and expression of the mtDNA depends on nuclear encoded proteins. Vice versa, the nucleus is a beneficiary of the energy currency within mitochondria [49] . Thus, alterations of the more vulnerable mtDNA might have dominant influences on the cross-talk between both genomes. For example, blocking the expression of mitochondrial gene products by ethidium bromide results in a failure for correct assembly and insertion into the inner mitochondrial membrane of most nuclear encoded respiratory chain subunits [50] . As noted recently by Avise [49] , the exclusive maternal inheritance of the mtDNA can have negative influence on male fitness, a phenomenon demonstrated in a number of examples in the literature. With respect to Type i diabetes, several experimental observations could be related to this puzzling fact. Administration of STZ to rats and mice and the intake of the poison Vakor [51, 52] in man causes diabetes. mainly in males. Parental consumption of smoked/cured mutton, which is rich in N-nitroso compounds, leads to diabetes preferentially in the following male generation [53] . There are also several examples for protective maternal influence on penetrance and severity of a nuclear gene defect, for instance, in Huntington's disease and in myotonic dystrophy [54] . Also in Type 1 diabetes the prevalence is lower in children from affected mothers than fathers [55] . Since all children derive their mtDNA from their mothers, co-transmission of maternal genes might represent a relatively protective factors. In general. the penetrance of a disease allele in a genetically programmed individual depends on its interaction with alleles of additional unlinked loci, on environmental agents and random factors [56] . If environmental noxae alter mtDNA this can become not only a catastrophic event for an individual, but could also initiate changes in population genetics on a relatively rapidly evolving level.
The mitochondrial oxidative phosphorylation as a matrix for ageing and degenerative disorders
Wallace has recently summarized [57] the basic concepts in the oxidative phosphorylation (OXPHOS) paradigm for degenerative diseases. Highly oxidative tissues such as brain, skeletal muscle, heart, kidney, liver and pancreatic islets depend on the capacity of the mitochondrial ATP generating system for their respectively specialized functions. Experimental inhibition of the respiratory chain and of oxidative phosphorylation results in an impairment of special tissue functions such as insulin production and secretion in Beta cells. The concept supposes that individuals normally start at the beginning of their lives with a high OXPHOS capacity. Due to defect accumulation of the mtDNA or of the nDNA or both, OXPHOS capacity declines with age. When the ATP production falls below a cell-specific energetic threshold the cell will be unable to function [38] . The maternally inherited mtDNA polymorphisms influence OXPHOS capacity, for example the maximal oxygen uptake and the response to endurance training [58] . Most of the random mutational events which underly the population specific mtDNA lineages seem to be neutral. However, this only means that they do not alter the functionality of OXPHOS capacity to a degree which reaches disease quality. In addition, even phenotypically silent mutations could slightly alter the functionality of the energy producing apparatus of the mitochondrion. The result could be either lower or higher susceptibility for a disease in an otherwise programmed individual, in affected families or even in populations.
mtDNA phylogenetics and disease
Encephalomyopathies such as MELAS, MERRF and LHON are characterized at the mtDNA level by distinct mutations, while some degenerative disorders such as Parkinson's disease, dilatative and hypertrophic cardiomyopathies are associated with deletions of the mt genome. Recently it has become evident that, in most cases, distinct mutations are not the only cause of a respective mt disease. By sequencing the mt genome of patients with Parkinson's disease, cardiomyopathy, MERRF or MELAS, Ozawa et al. [59] were able to demonstrate that these patients carry similar mtDNA clusters. From these clusters a phylogenetic tree was constructed, indicating that the patients, although suffering from phenotypically quite different disorders, belong to the same mt gene family. It also turned out that not a particular mutation, but the type and total number of mutations are indispensible factors for the disease. Similar results were published recently for the maternally inherited LHON demonstrating that the accumulation of synergistically interacting mutations of the mt genome, i. e. the degree of polymorphism, is responsible for the manifestation of a mitochondrial disease [601.
Since respective studies are lacking, one can only speculate whether population specific mtDNA lineages represent different possible targets for an environmental attack, thus possibly providing an explanation for the extraordinary geographic differences of the incidence rates of Type i diabetes.
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